Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 4, 2011

Amarantus and Generex to Develop Cell Replacement Therapy for Late-Stage Diabetes

  • Amarantus BioSciences and Generex Biotechnology are inking a third diabetes research collaboration. The companies will use Amarantus' PhenoGuard cell immortalization process to develop beta-cell replacement therapies.

    Amarantus and Generex previously inked separate deals to develop the former’s anti-apoptosis therapeutic protein known as MANF and Generex’ buccal insulin spray technology called Oral-lyn™, currently in a Phase III trial. The most recent arrangement not only covers work on a cell replacement therapy but also a MANF-based diagnostic test. The test will be designed to identify a subpopulation of patients who are at risk of developing type 1 or type 2 diabetes.

    "To date the Amarantus PhenoGuard technologies have been able to immortalize cells in a manner that maintains the phenotypic characteristics of the cells being immortalized," says John Commissiong, CSO of Amarantus.

    James Anderson, senior scientific advisor and director of Generex, adds, "The potential of Amarantus' proprietary PhenoGuard cell immortalization process to create a stable source of representative beta cells that can be used in cell replacement therapy in patients who have lost virtually all beta cell function represents a potential major breakthrough for the treatment of chronic, late-stage diabetes."



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »